Compare doctor-supervised GLP-1 weight loss programs — semaglutide, tirzepatide, and needle-free options — with transparent pricing, provider access, and shipping details all in one place.
Sponsored partner listing. We may earn a commission — at no cost to you.
Last reviewed September 2026 · Some listings are sponsored partner placements — this never changes our rankings. Always confirm current pricing on the partner's site.
From questionnaire to doorstep delivery in four steps — no clinic visits, no waiting rooms.
1
Compare Programs
Review pricing, medication options (semaglutide vs. tirzepatide), and provider support levels here on Our Healthier Life.
2
Digital Health Intake
Complete your chosen program's short online questionnaire — medical history, current medications, and goals.
3
Provider Review
A US-licensed provider reviews your intake and confirms whether you're clinically eligible. You pay nothing if you're not approved.
4
Doorstep Delivery
Approved prescriptions are dispensed by a licensed pharmacy and shipped with supplies, cold-chain, and tracking.
Clinical Education
Semaglutide vs. Tirzepatide: Key Differences
Understand how modern incretin therapies work before you compare programs.
GLP-1 receptor agonist
Semaglutide
Semaglutide mimics the natural GLP-1 hormone your gut releases after eating. It signals satiety to the brain, slows gastric emptying, and helps you feel satisfied with smaller meals — the mechanism behind the “quieter food noise” many patients report.
Typical cost: from ~$99–$199/month at online programs
Administration: weekly injection, or daily oral tablets at select programs
Track record: the longest safety and efficacy history of the class
Dual GIP / GLP-1 agonist
Tirzepatide
Tirzepatide activates two incretin receptors — GIP and GLP-1 — rather than one. In phase-3 trials it has generally produced the highest average weight reduction of any approved therapy, which is why it anchors the upper tier of most comparison lists.
Typical cost: from ~$144–$299/month at online programs
Administration: weekly injection
Clinical profile: highest average weight reduction reported in trials
Educational information only — not medical advice. Individual results vary. Discuss medication options with a licensed provider.
Common Questions
Frequently Asked Questions
Key facts about online GLP-1 consultations, prescriptions, and pricing.
Yes. Semaglutide and tirzepatide are prescription medications in the United States. Every program we list includes an evaluation by a US-licensed provider who writes the prescription only if you meet clinical eligibility criteria.
You complete a digital health intake, a licensed provider reviews your history, and — if approved — your prescription is dispensed by a pharmacy and shipped to your door with supplies. Follow-up care happens through messaging, app check-ins, or video visits depending on the program.
In our current comparison, doctor-supervised injection programs start at about $99.97 per month for compounded semaglutide, with most programs between $119 and $199. Needle-free tablet options run higher (around $239–$249), nutrition and support products start near $30, and the no-prescription supplement sits under $40 per bottle. See our full comparison for current pricing.
Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GIP/GLP-1 agonist. In phase-3 trials, tirzepatide has generally shown higher average weight loss, while semaglutide has a longer track record. Your provider can help you choose — this site is educational only and does not give medical advice.
The most commonly reported effects are nausea, constipation, and fatigue, especially during dose increases. Most people adjust within a few weeks. Serious complications are rare but possible, which is why provider supervision matters. Always discuss side effects with your clinician.
We earn commissions from some partner programs when visitors click through and complete a purchase or consultation — at no extra cost to you. Compensation does not change our rankings or editorial standards; see our affiliate disclosure for details.
